Literature DB >> 2757896

The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man.

P H Seidelin1, J J McMurray, R A Brown, A D Struthers.   

Abstract

1. The renin-angiotensin-aldosterone-system is important for the maintenance of sodium balance in man. Recent animal evidence suggests the angiotensin II can modulate the effect of the renal sympathetic nervous system on renal function. We have investigated the possible interaction of physiological doses of angiotensin II and noradrenaline on sodium excretion in man. 2. Seven normal volunteers were studied on four occasions during maximum water diuresis sustained by oral hydration. Samples were obtained during a baseline and four subsequent 20 min periods (A-E). Placebo or noradrenaline was infused over periods B-E, and angiotensin II infused over period C. 3. There was no change in systemic blood pressure, heart rate or creatinine clearance caused by infusion of either angiotensin II, noradrenaline or both in combination. 4. Noradrenaline alone caused a significant fall in absolute and fractional sodium excretion. Angiotensin II when infused with placebo caused a 37% fall in absolute sodium excretion and a 32% fall when infused with noradrenaline (no significant difference between the 2 days). Similar changes were seen for urinary flow and fractional sodium excretion. 5. We have therefore found no evidence to support a postsynaptic interaction of low doses of angiotensin II and noradrenaline on renal sodium excretion in man.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757896      PMCID: PMC1379808          DOI: 10.1111/j.1365-2125.1989.tb03443.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  28 in total

1.  The effect of angiotensin II on endogenous noradrenaline release in man.

Authors:  P H Seidelin; W J Coutie; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

2.  Role of angiotensin II in the altered renal function of heart failure.

Authors:  I Ichikawa; V Kon; M A Pfeffer; J M Pfeffer; B M Brenner
Journal:  Kidney Int Suppl       Date:  1987-05       Impact factor: 10.545

Review 3.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

4.  Stimulation of renal sodium reabsorption by angiotensin II.

Authors:  M D Johnson; R L Malvin
Journal:  Am J Physiol       Date:  1977-04

Review 5.  Role of the intrarenal renin-angiotensin system in the control of renal function.

Authors:  N R Levens; M J Peach; R M Carey
Journal:  Circ Res       Date:  1981-02       Impact factor: 17.367

6.  Effect of sodium intake on plasma catecholamines in normal subjects.

Authors:  M S Romoff; G Keusch; V M Campese; M S Wang; R M Friedler; P Weidmann; S G Massry
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

7.  Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines.

Authors:  K Jie; P Van Brummelen; P Vermey; P B Timmermans; P A Van Zwieten
Journal:  Eur J Clin Invest       Date:  1987-04       Impact factor: 4.686

8.  Stability and inter-relationships of hormone, haemodynamic and electrolyte levels in heart failure in man.

Authors:  M A Fitzpatrick; M G Nicholls; H Ikram; E A Espiner
Journal:  Clin Exp Pharmacol Physiol       Date:  1985 Mar-Apr       Impact factor: 2.557

9.  Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion.

Authors:  V Kon; A Yared; I Ichikawa
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

10.  Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.

Authors:  D Robertson; G A Johnson; R M Robertson; A S Nies; D G Shand; J A Oates
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.